R. Cameron

717 total citations
14 papers, 506 citations indexed

About

R. Cameron is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, R. Cameron has authored 14 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 1 paper in Surgery. Recurrent topics in R. Cameron's work include Asthma and respiratory diseases (10 papers), Inhalation and Respiratory Drug Delivery (5 papers) and Respiratory and Cough-Related Research (5 papers). R. Cameron is often cited by papers focused on Asthma and respiratory diseases (10 papers), Inhalation and Respiratory Drug Delivery (5 papers) and Respiratory and Cough-Related Research (5 papers). R. Cameron collaborates with scholars based in United Kingdom, Switzerland and Germany. R. Cameron's co-authors include Mark Higgins, Ronald Dahl, David Lawrence, Marc Decramer, David Young, Kenneth R. Chapman, Danny McBryan, Carlos Cézar Fritscher, Gilles Devouassoux and Muhammad Shoaib and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, European Respiratory Journal and Thorax.

In The Last Decade

R. Cameron

13 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Cameron United Kingdom	10	467	382	27	19	16	14	506
J Małolepszy Poland	6	349 0.7×	374 1.0×	13 0.5×	13 0.7×	5 0.3×	10	452
Andrzej Dymek Poland	6	303 0.6×	310 0.8×	19 0.7×	19 1.0×	3 0.2×	13	348
Richard Forth United Kingdom	11	395 0.8×	411 1.1×	10 0.4×	23 1.2×	7 0.4×	24	447
Lisa Sanford United States	6	451 1.0×	384 1.0×	123 4.6×	13 0.7×	9 0.6×	9	602
Gail Shapiro United States	9	464 1.0×	487 1.3×	10 0.4×	20 1.1×	2 0.1×	12	541
Jeremy Cole United States	8	85 0.2×	174 0.5×	20 0.7×	9 0.5×	16 1.0×	19	277
Adrian Butler United Kingdom	8	156 0.3×	202 0.5×	17 0.6×	5 0.3×	4 0.3×	8	274
Alessandro Guasconi Italy	6	474 1.0×	357 0.9×	6 0.2×	2 0.1×	7 0.4×	23	493
Catherine Francisco Italy	4	610 1.3×	482 1.3×	5 0.2×	2 0.1×	13 0.8×	6	628
Kuniaki Hirai Japan	8	97 0.2×	184 0.5×	17 0.6×	2 0.1×	14 0.9×	20	264

Countries citing papers authored by R. Cameron

Since Specialization

Citations

This map shows the geographic impact of R. Cameron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Cameron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Cameron more than expected).

Fields of papers citing papers by R. Cameron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Cameron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Cameron. The network helps show where R. Cameron may publish in the future.

Co-authorship network of co-authors of R. Cameron

This figure shows the co-authorship network connecting the top 25 collaborators of R. Cameron. A scholar is included among the top collaborators of R. Cameron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Cameron. R. Cameron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Cameron, R., et al.. (2021). 330: Patient valuation of health-related quality of life associated with treatment burden and pulmonary exacerbation in cystic fibrosis. Journal of Cystic Fibrosis. 20. S158–S158. 2 indexed citations

Rossi, Andrea, Thys van der Molen, Alberto Papi, et al.. (2015). INSTEAD: Randomized switch trial of indacaterol and salmeterol/fluticasone combination (SFC) in moderate COPD: Symptoms results. PA1023–PA1023. 1 indexed citations

Rossi, Andrea, Thys van der Molen, Alberto Papi, et al.. (2014). INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD. European Respiratory Journal. 44(6). 1548–1556. 90 indexed citations

Decramer, Marc, Kenneth R. Chapman, Ronald Dahl, et al.. (2013). Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study. The Lancet Respiratory Medicine. 1(7). 524–533. 194 indexed citations

Cameron, R., et al.. (2012). P128 Practise Patterns in Idiopathic Pulmonary Fibrosis: Results of a UK Physician Survey. Thorax. 67(Suppl 2). A117.2–A118. 3 indexed citations

Winter, J H, et al.. (2009). Chest X-rays in COPD screening: Are they worthwhile?. Respiratory Medicine. 103(12). 1862–1865. 13 indexed citations

Kanniess, Frank, Louis‐Philippe Boulet, Władysław Pierzchała, et al.. (2008). Efficacy and Safety of Indacaterol, a New 24-hourβ₂-Agonist, in Patients with Asthma: A Dose-Ranging Study. Journal of Asthma. 45(10). 887–892. 15 indexed citations

Yang, William H., Jean‐Benoît Martinot, Petr Pohunek, et al.. (2007). Tolerability of indacaterol, a novel once-daily β2-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety study. Annals of Allergy Asthma & Immunology. 99(6). 555–561. 21 indexed citations

Чучалин, А. Г., Kai Richter, Norbert Krug, et al.. (2007). Safety and tolerability of indacaterol in asthma: A randomized, placebo-controlled 28-day study. Respiratory Medicine. 101(10). 2065–2075. 36 indexed citations

10.

Derom, Eric, et al.. (2007). Indacaterol, a novel inhaled β₂-agonist, provides sustained 24-h bronchodilation in asthma. European Respiratory Journal. 29(5). 871–878. 49 indexed citations

11.

LaForce, Craig, Michael J. Alexander, Leonardo M. Fabbri, et al.. (2007). Indacaterol provides sustained 24 h bronchodilation on once‐daily dosing in asthma: a 7‐day dose‐ranging study. Allergy. 63(1). 103–111. 35 indexed citations

12.

Grönke, Lars, Kai Michael Beeh, R. Cameron, et al.. (2007). Effect of the oral leukotriene B4 receptor antagonist LTB019 on inflammatory sputum markers in patients with chronic obstructive pulmonary disease. Pulmonary Pharmacology & Therapeutics. 21(2). 409–417. 23 indexed citations

13.

Kanniess, Frank, R. Cameron, Ryan Owen, & Mark Higgins. (2006). Indacaterol, A Novel Once-Daily β2-Agonist, Demonstrates 24-hour Efficacy and is Well Tolerated in Patients with Persistent Asthma. Journal of Allergy and Clinical Immunology. 117(2). S196–S197. 3 indexed citations

14.

Fisher, Samuel R., et al.. (1990). Free jejunal interposition graft for reconstruction of the esophagus. Head & Neck. 12(2). 126–130. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact